Hints and tips:
...The antitrust challenge may force big pharma groups to rethink “pure play” business models. The Lex team is interested in hearing more from readers. Is the FTC right to challenge pharma deals?...
...This nascent healthcare group would quickly establish itself as go-to advisers to various big pharma clients including Pfizer....
Vigorous challenge is vowed as private lender takes over French pharma group Laboratoire XO
...Here are numbers 8, 9, 11, 12 and 14, which will also enjoy all the advantages of being absolutely immense companies: Here are a diversified healthcare company (in pharma, medical equipment, and consumer...
...Reliance has recently invested in healthcare companies including genetics group Strand Life Sciences, after buying a majority stake in pharma sales company Netmeds in 2020....
...A third of the index is flat or down from a year ago, spread across sectors (tech, retail, pharma) and from growth (Lululemon) to value (Amgen). Valuations are starting to come in, too....
...The controversial strategy re-entered the spotlight when Jones Day was enlisted by Johnson & Johnson to engineer a Texas two-step last autumn, as the number of lawsuits alleging the pharma group’s baby talcum...
...He previously led pharma and life sciences M&A at Alantra. Smart reads Taking on Tesla Civil rights lawyer Larry Organ is challenging the world’s most valuable carmaker in court, and winning....
...(BBG) Big Pharma lobbies again While big US tech groups have said they support plans for a new, sweeping global tax deal, big pharmaceutical companies are quietly pushing back against it....
...AstraZeneca has named Aradhana Sarin as its next CFO following its takeover of Alexion Pharma, where she held the same role....
...Nasdaq has won two of the year’s biggest market debuts, the $2.5bn Royalty Pharma IPO and $2.2bn Warner Music listing, and has a third coming up: Airbnb, the accommodation booking group, which plans to sell...
...Royalty Pharma, a group that makes money from royalties on drugs, this week raised $2.2bn in the biggest listing of the year. Warner Music earlier this month sold $1.9bn of stock....
...But the pharma industry — bolstered by its scientific and regulatory expertise — has more to gain than lose....
...Christine Lemke, co-founder and president of Evidation, a health measurement platform that provides data analytics to tech and pharma companies, says one of Google’s key advantages is it can use unconventional...
...Companies such as BridgeBio Pharma and Adaptive Biotechnologies have raised hundreds of millions of dollars on Nasdaq this year, in part attracted by the exchange’s biotech index....
...A person close to senior executives at Bristol-Myers said the pharma group had been in touch with several large investors and was confident it would be backed by a majority of its shareholders....
...Pharma companies have typically found it hard to prove the value of their interventions in the field of preventive health....
...This can only be Avantor, whose debt-funded takeover of much larger publicly traded peer VWR saw the pharma group take on eye-watering leverage to pay $1.4bn of dividends to New Mountain Capital....
...The two largest overseas pharma companies in China by sales, AstraZeneca and Pfizer, both said China sales rose 24 per cent in the last quarter compared to the same period last year....
...According to Silvana van Schaik, manager for healthcare and chemicals at research provider Sustainalytics, the 2016 outcry persuaded some pharma companies, led by Ireland-headquartered Allergan, to commit...
...In a separate development, Compugen, an Israeli pharma company, said it had entered into an exclusive licence agreement with MedImmune that would enable the development of antibody products to treat cancer...
...Read more: Consumer drugs do not always work for big pharma Image source: Bloomberg...
....; Aurobindo Pharma USA, Inc.; Citron Pharma, LLC; Mayne Pharma (USA), Inc.; Mylan Pharmaceuticals, Inc.; Teva Pharmaceuticals USA; Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC...
...Poor compliance with drug regimes, particularly among sufferers of chronic diseases, is a pervasive problem for pharma companies and health systems, leading to lower consumption of the industry’s products...
...The private equity veteran sits on the boards of four other listed companies, including Kite Pharma and Caesars Entertainment Corporation....
International Edition